ID
16010
Description
A Phase III Trial For Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00191152
Link
https://clinicaltrials.gov/show/NCT00191152
Keywords
Versions (2)
- 5/2/16 5/2/16 -
- 6/26/16 6/26/16 -
Uploaded on
June 26, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00191152
Eligibility Breast Cancer NCT00191152
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
second primary malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0751623
Description
brain metastases
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
peripheral neuropathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0031117
Description
prior treatment with gemcitabine, capecitabine or taxane
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0045093
- UMLS CUI [2,1]
- C1514463
- UMLS CUI [2,2]
- C0045093
- UMLS CUI [3,1]
- C1514463
- UMLS CUI [3,2]
- C3541958
Description
active cardiac disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0018799
- UMLS CUI [1,2]
- C0205318
Description
concomitant herceptin therapy
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1707479
- UMLS CUI [1,2]
- C0338204
Similar models
Eligibility Breast Cancer NCT00191152
- StudyEvent: Eligibility
C0678222 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C0045093 (UMLS CUI [2,2])
C1514463 (UMLS CUI [3,1])
C3541958 (UMLS CUI [3,2])
C0205318 (UMLS CUI [1,2])
C0338204 (UMLS CUI [1,2])